Remove 2023 Remove FDA Remove Medical science Remove Sales
article thumbnail

Moving towards oral delivery of biologics

European Pharmaceutical Review

Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. This trial is anticipated to begin in the second half of 2023. Top companies and drugs by sales in 2021. Biologics Global Market Report 2023. 2023 [cited 2023Feb]. References Urquhart L.

article thumbnail

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Medgadget

Human Xtensions chose to proceed with direct sales of its technology in the U.S. Interestingly, due to FDA’s regulatory methodology, surgical robots have to be approved for specific indications by the agency. Because of its tiny domestic market, Israeli firms typically end up joining large conglomerates.